These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4359836)

  • 21. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    Rider AK
    JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412
    [No Abstract]   [Full Text] [Related]  

  • 22. Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
    Mancini M; Postiglione A; Farinaro E; Montefusco S
    Prev Med; 1983 Nov; 12(6):848-53. PubMed ID: 6676732
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the treatment of hyperlipoproteinaemia type II with cholestyramine (author's transl)].
    Válek J; Pechar J; Hrubá F
    Cas Lek Cesk; 1973 Dec; 112(49):1531-4. PubMed ID: 4358602
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of hypercholesterolemia. Combined dietary, surgical, and bile salt-binding resin therapy.
    Buckwald H; Moore RB; Lee GB; Frantz ID; Varco RL
    Arch Surg; 1968 Aug; 97(2):275-82. PubMed ID: 5657433
    [No Abstract]   [Full Text] [Related]  

  • 25. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ileal bypass, surgical therapy of major pure hypercholesteremia (apropos of 2 cases)].
    Clot JP; Rouffy J; Loeper J; Mercadier M
    Chirurgie; 1971 Feb; 97(1):57-63. PubMed ID: 4996054
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of hypercholesterolemia by interference with bile acid metabolism.
    Grundy SM
    Arch Intern Med; 1972 Oct; 130(4):638-48. PubMed ID: 4562153
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of heterozygous type II hyperlipidemia by partial ileal bypass in a pediatric population.
    Schwartz MZ; Varco RL; Buchwald H
    J Pediatr Surg; 1976 Jun; 11(3):411-8. PubMed ID: 182951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia.
    Farah JR; Kwiterovich PO; Neill CA
    Adv Exp Med Biol; 1977; 82():212-5. PubMed ID: 200092
    [No Abstract]   [Full Text] [Related]  

  • 30. [Type II primary hyperlipoproteinemia: effect of dietary treatment and cholestyramine on serum lipids and lipoproteins].
    Vaverková H; Kubasta M; Zmeskal A; Procházka J; Vrublowský P; Podivínský
    Vnitr Lek; 1976 Jan; 22(1):73-83. PubMed ID: 175564
    [No Abstract]   [Full Text] [Related]  

  • 31. Ileal bypass in the treatment of hyperlipoproteinaemia.
    Thompson GR; Gotto AM
    Lancet; 1973 Jul; 2(7819):35-6. PubMed ID: 4123303
    [No Abstract]   [Full Text] [Related]  

  • 32. [Familial hyperlipoproteinemia type IIA with homozygotic manifestations in a heterozygote].
    Traurig J; Sobra J; Kvasilová M; Wildtová Z
    Vnitr Lek; 1978 Jul; 24(7):684-90. PubMed ID: 209627
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
    Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
    Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current concepts in genetics. The genetic hyperlipidemias.
    Motulsky AG
    N Engl J Med; 1976 Apr; 294(15):823-7. PubMed ID: 175274
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic failure in familial type II hyperlipoproteinemia.
    Witters LA; Herbert PN; Shulman RS; Krauss RM; Levy RI
    Metabolism; 1976 Sep; 25(9):1017-26. PubMed ID: 183084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study on serum lipids and atherosclerotic plaque formation in diet-induced and familial hypercholesterolemia in rabbits, and the effect of partial ileal bypass.
    van Niekerk JL; Demacker PN; Hendriks T; de Boer HH
    Artery; 1985; 12(4):263-76. PubMed ID: 4074136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Portacaval shunt in two patients with homozygous hypercholesterolemia.
    Stein EA; Mieny C; Pettifor J; Dinner M
    Adv Exp Med Biol; 1975; 63():405-16. PubMed ID: 173154
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of partial ileoshunting on hyperlipoproteinemia in patients with atherosclerosis].
    Sedletskiĭ IuI
    Vestn Khir Im I I Grek; 1985 Aug; 135(8):48-51. PubMed ID: 4060509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the protective effects of cholestyramine and ileal bypass in rhesus monkeys on an atherogenic regimen.
    Younger RK; Shepard GH; Butts WH; Scott HW
    Surg Forum; 1969; 20():101-3. PubMed ID: 4986400
    [No Abstract]   [Full Text] [Related]  

  • 40. [Homozygous familial hypercholesterolemia. Response to combined cholestyramine and lovastatin therapy].
    Obando Santaella I; Fernández Gómez E; Mongil Ruiz I; Escobar Gallego A; García Alegría JJ; Gascón Luna F; Masana Marín L
    An Esp Pediatr; 1990 Jul; 33(1):58-60. PubMed ID: 2252289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.